tiprankstipranks
Datametrex Ai (TSE:DM)
:DM

Datametrex AI Limited (DM) AI Stock Analysis

Compare
83 Followers

Top Page

TS

Datametrex AI Limited

(DM)

42Neutral
Datametrex AI Limited faces severe financial and operational challenges, reflected in declining revenues and profitability margins, and negative cash flows. The technical analysis indicates bearish momentum. However, recent positive corporate events, including strategic acquisitions and focus on healthcare and AI, provide some optimism for future growth potential.

Datametrex AI Limited (DM) vs. S&P 500 (SPY)

Datametrex AI Limited Business Overview & Revenue Model

Company DescriptionDatametrex AI Limited (DM) is a technology-focused company that operates primarily in the artificial intelligence and data analytics sectors. The company offers a suite of products and services designed to help businesses leverage AI for better decision-making and operational efficiency. Key offerings include AI-driven analytics platforms and solutions tailored for various industries, including healthcare, retail, and finance.
How the Company Makes MoneyDatametrex AI Limited generates revenue through multiple streams, predominantly from the sale and implementation of its AI-driven analytics solutions. The company earns money by providing subscription-based access to its software platforms, consulting services, and customized AI solutions. Additionally, Datametrex engages in partnerships with other tech companies to integrate its AI technology into broader systems, which can create additional revenue channels. The company may also benefit from governmental and private sector contracts where its technology is applied to specific industry needs.

Datametrex AI Limited Financial Statement Overview

Summary
Datametrex AI Limited is facing financial challenges, with declining revenue and consistent losses impacting profitability. The high leverage and limited equity raise concerns about financial stability, while negative cash flows suggest operational inefficiencies. Improvements in cost management and revenue growth are essential for better financial health.
Income Statement
30
Negative
The income statement reveals a declining revenue trend, with a significant decrease from previous years. The gross profit margin is negative, indicating higher costs than revenue. Net profit margin is also negative, showing consistent losses. EBIT and EBITDA margins are unfavorable, reflecting operational inefficiencies and high expenses relative to revenue.
Balance Sheet
45
Neutral
The balance sheet shows a high debt-to-equity ratio, indicating significant leverage, which can be risky. The equity ratio is low, suggesting limited shareholder equity relative to assets. While the company has substantial total assets, the low stockholders' equity and high liabilities point to potential financial instability.
Cash Flow
35
Negative
Cash flow analysis indicates negative operating and free cash flow, reflecting operational difficulties in generating cash. The free cash flow to net income ratio is unfavorable, highlighting inadequate cash generation relative to net losses. Although financing activities provided some cash, overall cash flow remains a concern.
Breakdown
TTMDec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Income StatementTotal Revenue
10.95M7.80M30.49M49.03M12.38M3.40M
Gross Profit
-47.27K2.17M10.20M21.03M2.99M1.49M
EBIT
-6.13M-5.80M-2.30M23.63M-4.26M-4.01M
EBITDA
-16.09M-6.95M-13.46M13.29M-3.52M-2.45M
Net Income Common Stockholders
-20.13M-19.14M-17.26M9.09M-5.01M-2.78M
Balance SheetCash, Cash Equivalents and Short-Term Investments
654.63K1.13M9.41M17.99M1.97M119.67K
Total Assets
9.32M12.71M36.00M42.64M10.00M7.91M
Total Debt
440.23K5.19M4.53M253.77K518.58K449.82K
Net Debt
-214.40K4.85M-4.41M-15.15M-1.45M330.15K
Total Liabilities
4.95M11.70M13.23M10.15M6.75M5.00M
Stockholders Equity
4.37M1.00M22.77M32.49M3.25M2.91M
Cash FlowFree Cash Flow
-3.56M-6.94M-2.28M11.42M-611.50K-1.23M
Operating Cash Flow
-3.45M-5.62M-249.09K11.45M-595.10K-1.18M
Investing Cash Flow
647.56K-969.15K-3.79M-234.41K-14.93K-300.03K
Financing Cash Flow
1.93M-254.18K-2.40M2.19M2.48M967.41K

Datametrex AI Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (57)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
57
Neutral
$20.94B10.43-13.41%2.52%4.53%-23.34%
TSPTK
44
Neutral
$407.34M-442.59%-78.34%-9.55%
TSDM
42
Neutral
C$1.65M-158.04%49.97%67.56%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:DM
Datametrex AI Limited
0.08
-0.67
-89.33%
TSE:PTK
POET Technologies
5.74
3.98
226.14%

Datametrex AI Limited Corporate Events

Executive/Board ChangesM&A TransactionsBusiness Operations and Strategy
Datametrex AI Limited to Acquire Arbutus Health and Wellness Inc.
Positive
Apr 1, 2025

Datametrex AI Limited has signed a non-binding Letter of Intent to acquire Arbutus Health and Wellness Inc., a multidisciplinary medical clinic in Vancouver, for up to $1.1 million through common shares. This strategic acquisition aims to expand Datametrex’s healthcare business, strengthen its sector presence, and align with its long-term growth strategy. Additionally, Richard Yoon has resigned from the Board of Directors, and the company is in the process of identifying a suitable replacement.

M&A TransactionsBusiness Operations and Strategy
Datametrex AI Limited Unveils Strategic Focus on Healthcare and AI
Positive
Feb 27, 2025

Datametrex AI Limited has announced a strategic plan to focus on its healthcare and AI businesses by expanding clinic operations and strengthening AI services. The company plans to acquire additional clinics, wind down non-core businesses, and split into two entities to enhance operational efficiency and shareholder value.

Delistings and Listing ChangesStock Split
Datametrex AI Announces Share Consolidation Effective Date
Neutral
Feb 18, 2025

Datametrex AI Limited has announced the effective date for its share consolidation, where its common shares will begin trading on a consolidated basis of one post-consolidation share for every thirty pre-consolidation shares on the TSX Venture Exchange. This move will adjust the total issued and outstanding number of shares to approximately 21,002,671, potentially impacting the company’s market dynamics and investor relations.

Stock SplitBusiness Operations and Strategy
Datametrex AI Limited Proposes Share Consolidation for Capital Optimization
Neutral
Feb 6, 2025

Datametrex AI Limited announced a proposed consolidation of its common shares, aiming to optimize the capital structure and attract financing. The consolidation will change the share ratio to one new share for every thirty existing shares, reducing the number of shares from 630,080,158 to 21,002,671, subject to regulatory approval. This move is expected to impact the company’s operations by potentially improving its financial flexibility and attractiveness to investors.

Business Operations and StrategyFinancial Disclosures
Datametrex AI Limited’s Subsidiary Secures $1.1M Service Order
Positive
Feb 6, 2025

Datametrex AI Limited announced that its subsidiary, Datametrex Korea, has received purchase orders valued at approximately $1.1 million for service and tech support, with a projected gross profit margin of 63%. This achievement highlights the company’s ongoing financial growth and its dedication to strengthening client partnerships and expanding its industry presence.

Datametrex AI Limited Secures New $440K Order, Reinforcing Industry Position
Jan 10, 2025

Datametrex AI Limited, through its subsidiary Datametrex Korea, has secured a new purchase order worth approximately $440,000, with an expected gross profit margin of 33%. This order underscores the company’s robust position in the IT industry, bolstered by its effective ‘land and expand’ strategy and strong partnerships with existing clients. The announcement reflects Datametrex’s commitment to innovation and delivering long-term value, reinforcing its growth trajectory in the AI and tech sectors.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.